Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.35 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12896185 | 0.73 | BCL2L1 (0.39) | HTR2BCYP2A6KDM4ELMNACYP1A2 | |
| SCHEMBL12896160 | 0.73 | ALB (0.38) | HTR2BCYP2A6LMNACYP1A2 | |
| SCHEMBL12896161 | 0.71 | ESR1 (0.40) | TDP1 | |
| SCHEMBL12896176 | 0.71 | BCKDK (0.38) | KDM4ELMNA | |
| SCHEMBL11990859 | 0.71 | GPR3 (0.46) | NQO1CYP2A6TDP1HSD17B10CYP1A2 | |
| SCHEMBL30888167 | 0.71 | GPR3 (0.46) | NQO1CYP2A6TDP1HSD17B10CYP1A2 | |
| SCHEMBL14295231 | 0.70 | RAB9A (0.42) | UGT2B7NQO1LMNACYP1A2 | |
| SCHEMBL16024612 | 0.69 | GPR3 (0.43) | NQO1CYP2A6TDP1HSD17B10 | |
| SCHEMBL752667 | 0.69 | GPR3 (0.43) | NQO1CYP2A6TDP1KDM4EHSD17B10 | |
| SCHEMBL23776184 | 0.68 | LMNA (0.36) | UGT2B7HTR2AHTR2CHTR2BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9780315-B2 | Heteroacene compounds for organic electronics | BASF SE (DE) | 2017-10-03 | — | — | US | disclosed |
| US-20150318496-A1 | HETEROACENE COMPOUNDS FOR ORGANIC ELECTRONICS | CLAP CO., LTD. (KR) | 2015-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150318496-A1 | HETEROACENE COMPOUNDS FOR ORGANIC ELECTRONICS | AP1M1, AP3M1, BMI1 | UGT2B7 1558/4885NQO1 236/4885HTR2A 1134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.